Eledon Pharmaceuticals
ELDN
ELDN
121 hedge funds and large institutions have $131M invested in Eledon Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% more funds holding
Funds holding: 95 → 121 (+26)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17.48% less ownership
Funds ownership: 73.67% → 56.19% (-17%)
Holders
121
Holding in Top 10
1
Calls
$649K
Puts
$38K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.78M | |
| 3 | +$897K | |
| 4 |
CCM
Catalio Capital Management
New York
|
+$895K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$872K |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$2M | |
| 3 | -$1.2M | |
| 4 |
ZP
Zimmer Partners
New York
|
-$1.2M |
| 5 |
Jane Street
New York
|
-$1.15M |
